Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study

American Journal of Epidemiology

Volumn 177, Issue 8, 2013, Pages 776-786

  Hofmann, Jonathan N ^a   Moore, Steven C ^a   Lim, Unhee ^a   Park, Yikyung ^a   Baris, Dalsu ^a   Hollenbeck, Albert R ^a   Matthews, Charles E ^a   Gibson, Todd M ^a   Hartge, Patricia ^a   Purdue, Mark P ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

body mass index; multiple myeloma; obesity; overweight; physical activity

Indexed keywords

ACTIVITY PATTERN; ADULT; BODY MASS; COHORT ANALYSIS; DIET; HEALTH RISK; OBESITY; QUESTIONNAIRE SURVEY; RISK FACTOR; WEIGHT;

ADULT; ADULTHOOD; AGED; ARTICLE; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; CORRELATIONAL STUDY; ENERGY BALANCE; FEMALE; GROUPS BY AGE; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OBESITY; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT;

ADIPOSITY; AGED; BODY MASS INDEX; CONFIDENCE INTERVALS; DIET SURVEYS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIPLE MYELOMA; NATIONAL INSTITUTES OF HEALTH (U.S.); OBESITY; ODDS RATIO; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; WEIGHT GAIN;

UNITED STATES;

EID: 84876244762     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws295     Document Type: Article

References (30)

1. American Cancer Society. Cancer Facts & Figures 2010. Atlanta, GA: American Cancer Society; 2010.
2. De Roos AJ, Baris D, Weiss NS, et al. Multiple myeloma. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006:919-945.
3. Wallin A, Larsson SC. Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer. 2011;47(11):1606-1615.
4. De Roos AJ, Ulrich CM, Ray RM, et al. Intentional weight loss and risk of lymphohematopoietic cancers. Cancer Causes Control. 2010;21(2):223-236.
5. Lu Y, Sullivan-Halley J, Henderson KD, et al. Anthropometric characteristics and multiple myeloma risk. Epidemiology. 2010;21(2):272-273.
6. Pylypchuk RD, Schouten LJ, Goldbohm RA, et al. Body mass index, height, and risk of lymphatic malignancies: a prospective cohort study. Am J Epidemiol. 2009;170(3): 297-307.
7. Troy JD, Hartge P, Weissfeld JL, et al. Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Epidemiol. 2010; 171(12):1270-1281.
8. Blair CK, Cerhan JR, Folsom AR, et al. Anthropometric characteristics and risk ofmultiple myeloma. Epidemiology. 2005;16(5):691-694.
9. Britton JA, Khan AE, Rohrmann S,etal. Anthropometric characteristics and non-Hodgkin's lymphoma and multiple myeloma risk in the European Prospective Investigation Into Cancerand Nutrition (EPIC). Haematologica. 2008;93(11):1666-1677.
10. Mac Innis RJ, English DR, Hopper JL, et al. Body size and composition and the risk of lymphohematopoietic malignancies. J Natl Cancer Inst. 2005;97(15):1154-1157.
11. Birmann BM, Giovannucci E, Rosner B,etal. Body mass index, physical activity, and risk of multiple myeloma. Cancer Epidemiol Biomarkers Prev. 2007;16(7):1474-1478.
12. Schatzkin A, Subar AF, Thompson FE, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions :the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am JEpidemiol. 2001;154(12):1119-1125.
13. Michaud DS, Midthune D, Hermansen S, et al. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. JRegistry Manag. 2005;32(2):70-75.
14. Fritz A, Percy C, Jack A, et al. eds. International Classification of Diseases for Oncology, Third Edition. Geneva, Switzerland:World Health Organization; 2000. Physical status:the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1-452.
15. Moore SC, Rajaraman P, Dubrow R, et al. Height, body mass index, and physical activity in relation to glioma risk. Cancer Res. 2009;69(21):8349-8355.
16. Perry GS, Byers TE, Mokdad AH, et al. The validity of self-reports ofpastbody weights by U.S. adults. Epidemiology. 1995;6(1):61-66.
17. Khan MM, Mori M, Sakauchi F, et al. Risk factors for multiple myeloma:evidence from the Japan Collaborative Cohort (JACC) study. Asian Pac J Cancer Prev. 2006;7(4):575-581.
18. Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk:new perspectives. Annu Rev Med. 2010;61:301-316.
19. Frisch M, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285(13):1736-1745.
20. Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients:a meta-analysis. Lancet. 2007;370(9581):59-67.
21. Quinlan SC, Morton LM, Pfeiffer RM, et al. Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1229-1237.
22. Klein B, Tarte K, Jourdan M, et al. Survival and proliferation factors of normal and malignant plasma cells. Int J Hematol. 2003;78(2):106-113.
23. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 1997;82(12):4196-4200.
24. Tilg H, Moschen AR. Adipocytokines:mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772-783.
25. Dalamaga M, Karmaniolas K, Panagiotou A, et al. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk:a case-control study. Cancer Causes Control. 2009;20(2):193-199.
26. Ferlin M, Noraz N, Hertogh C, et al. Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6- independent transduction pathway. Br J Haematol. 2000;111(2):626-634.
27. Sprynski AC, Hose D, Caillot L, et al. The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor. Blood. 2009; 113(19):4614-4626.
28. Engeland A, Tretli S, Hansen S, et al. Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol. 2007;165(1):44-52.
29. Ferrari P, Friedenreich C, Matthews CE. The role of measurement error in estimating levels ofphysical activity. Am J Epidemiol. 2007;166(7):832-840.
30. Winters-Hart CS, Brach JS, Storti KL, et al. Validity of a questionnaire to assess historical physical activity in older women. Med Sci Sports Exerc. 2004;36(12):2082-2087.